Concepedia

Josine M.M.F. Quispel-Janssen

JM

5

Publications

590

Citations

5

H-Index

2017

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Josine M.M.F. Quispel-Janssen is an author at The Netherlands Cancer Institute specializing in radiation oncology, oncology, and medicine.

ORCID

Top concepts

Publications per year

2017–2019

5

Publications

5

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Josine M.M.F. Quispel-Janssen, Vincent van der Noort, Jeltje F. de Vries et al. · Journal of Thoracic Oncology · 2018 · 244 citations · Full text

Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial

Maria Disselhorst, Josine M.M.F. Quispel-Janssen, Ferry Lalezari et al. · The Lancet Respiratory Medicine · 2019 · 243 citations

, , +2

OA13.01 A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): with Translational Research (TR) Biopies

Josine M.M.F. Quispel-Janssen, Giulia Zago, Robert D. Schouten et al. · Journal of Thoracic Oncology · 2017 · 52 citations · Full text

, , +4

Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition

Josine M.M.F. Quispel-Janssen, Jitendra Badhai, Laurel M. Schunselaar et al. · Clinical Cancer Research · 2017 · 39 citations

Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical Responses

Laurel M. Schunselaar, Josine M.M.F. Quispel-Janssen, Yongsoo Kim et al. · Clinical Cancer Research · 2017 · 12 citations · Full text

Rows per page

1–5 of 5